121 related articles for article (PubMed ID: 17465207)
1. Functional alteration of myeloid dendritic cells through head and neck cancer.
Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor interference in myeloid dendritic cells through head and neck cancer.
Frenzel H; Hoffmann B; Brocks C; Schlenke P; Pries R; Wollenberg B
Anticancer Res; 2006; 26(6B):4409-13. PubMed ID: 17201162
[TBL] [Abstract][Full Text] [Related]
3. Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein.
Frenzel H; Pries R; Brocks CP; Jabs WJ; Wittkopf N; Wollenberg B
Anticancer Res; 2007; 27(6B):4111-5. PubMed ID: 18225580
[TBL] [Abstract][Full Text] [Related]
4. Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells.
Thiel A; Pries R; Jeske S; Trenkle T; Wollenberg B
Anticancer Res; 2009 Aug; 29(8):3019-25. PubMed ID: 19661310
[TBL] [Abstract][Full Text] [Related]
5. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
[TBL] [Abstract][Full Text] [Related]
6. Isolation of human myeloid dendritic cells from tumor tissue and peripheral blood.
Brocks C; Graefe H; Frenzel H; Pries R; Wollenberg B
In Vivo; 2006; 20(2):239-42. PubMed ID: 16634524
[TBL] [Abstract][Full Text] [Related]
7. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood.
Nitsch SM; Pries R; Wollenberg B
In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359
[TBL] [Abstract][Full Text] [Related]
8. Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma.
Pries R; Thiel A; Brocks C; Wollenberg B
In Vivo; 2006; 20(1):45-8. PubMed ID: 16433027
[TBL] [Abstract][Full Text] [Related]
9. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
[TBL] [Abstract][Full Text] [Related]
10. Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck.
Kacani L; Wurm M; Schwentner I; Andrle J; Schennach H; Sprinzl GM
Oral Oncol; 2005 Jan; 41(1):17-24. PubMed ID: 15598581
[TBL] [Abstract][Full Text] [Related]
11. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
12. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA
Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944
[TBL] [Abstract][Full Text] [Related]
13. IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro.
Egan JE; Quadrini KJ; Santiago-Schwarz F; Hadden JW; Brandwein HJ; Signorelli KL
J Immunother; 2007 Sep; 30(6):624-33. PubMed ID: 17667526
[TBL] [Abstract][Full Text] [Related]
14. Increased cytokine secretion in head and neck cancer upon p38 mitogen-activated protein kinase activation.
Riebe C; Pries R; Kemkers A; Wollenberg B
Int J Mol Med; 2007 Dec; 20(6):883-7. PubMed ID: 17982698
[TBL] [Abstract][Full Text] [Related]
15. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells.
Lathers DM; Achille N; Kolesiak K; Hulett K; Sparano A; Petruzzelli GJ; Young MR
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):205-12. PubMed ID: 11555755
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells and HNSCC: a potential treatment option? (Review).
Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
[TBL] [Abstract][Full Text] [Related]
19. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma.
Kato H; Whiteside TL
Tokai J Exp Clin Med; 2011 Dec; 36(4):144-51. PubMed ID: 22167499
[TBL] [Abstract][Full Text] [Related]
20. Cytokines in head and neck cancer.
Pries R; Wollenberg B
Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]